Publications

1. Briggs LG, Parke SC, Beck KL, Sinha D, Gill V, Van Ligten MJ, Bain PA, Tyson MD 2nd, Abdul-Muhsin HM, Quillen JK, Dodoo CA, De Luigi AJ, Branstiter NL, Trinh QD, Psutka SP. Prehabilitative/rehabilitative exercise, nutrition, and psychological support for bladder cancer: A scoping review of randomized clinical trials. Cancer. 2024 Nov 2 Epub 2024 Nov 02
   View PubMed
2. Warren CJ, Mauler D, Butterfield D 3rd, Wymer K, Khan A, Humphreys MR, Tyson MD, Punjani N. A Tale of 102,726 Messages: Characterizing the Modern Urologist's Portal Message Burden After Common Urologic Surgeries. Urol Pract. 2024 Oct 9; 101097UPJ0000000000000718 Epub 2024 Oct 09
   View PubMed
3. Choudry MM, Durant AM, Edmonds VS, Warren CJ, Kunze KL, Golafshar MA, Nielsen SM, Esplin ED, Andrews JR, Samadder NJ, Tyson MD. Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study. J Urol. 2024 Oct; 212 (4):590-599 Epub 2024 June 11
   View PubMed
4. Durant AM, Mayes CJ, Tyson MD. Testicular cancer malpractice trends. Urol Oncol. 2024 Sep 16 Epub 2024 Sept 16
   View PubMed
5. Salevitz D, Olson K, Klanderman M, Mi L, Tyson M, Humphreys M, Misra L. Intraoperative magnesium sulfate is not associated with improved pain control after urologic procedures. Perioper Med (Lond). 2024 Sep 6; 13 (1):91 Epub 2024 Sept 06
   View PubMed
6. Ladi-Seyedian SS, Ghoreifi A, Konety B, Pohar K, Holzbeierlein JM, Taylor J, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S. Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry. Cancers (Basel). 2024 Mar 24; 16 (7)
   View PubMed
7. Myers A, Ristau B, Mossanen M, Tyson MD, Chisolm S, Sloan F, Ball CT, Smith A, Lyon TD. Patient reported treatment burden and attitudes towards in-home intravesical therapy among patients with bladder cancer. Urol Oncol. 2024 Feb; 42 (2):29.e17-29.e22 Epub 2023 Nov 22
   View PubMed
8. Tyson MD. Single incision robotic cystectomy and urinary diversion. World J Urol. 2024 Jan 20; 42 (1):45
   View PubMed
9. Tyson MD, Abouassaly R, Durant A, Smith AB, Seemann K, Shoskes DA. Reply by Authors. Urol Pract. 2024 Jan; 11 (1):60 Epub 2024 Jan 01
   View PubMed
10. Durant AM, Choudry MM, Madura G, Mi L, Faraj KS, Tyson MD. Bacillus Calmette-Guerin (BCG) therapy is safe and effective in non-muscle invasive bladder cancer (NMIBC) patients with immunomodulating conditions. Urol Oncol. 2024 Jan; 42 (1):21.e21-21.e28 Epub 2023 Oct 16
    View PubMed
11. Tyson MD, Abouassaly R, Durant A, Smith AB, Seemann K, Shoskes DA. Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients. Urol Pract. 2024 Jan; 11 (1):54-60 Epub 2023 Nov 01
    View PubMed
12. Chang SS, Li R, Prasad SM, Steinberg GD, Tyson MD. Therapeutic approaches in non-muscle invasive bladder cancer. Urology Times. 2024; 52 (2):22-3
    
13. Durant AM, Whitney MA, Chang YH, Larson MA, Shah PH, Lyon TD, Humphreys MR, Etzioni DA, Tyson MD 2nd. Surgical Site Infections in Open and Laparoscopic Operations in Rooms With Open-floor Drainage Systems. Urol Pract. 2023 Nov; 10 (6):622-629 Epub 2023 July 27
    View PubMed
14. Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study. J Urol. 2023 May; 209 (5):890-900 Epub 2023 Apr 07
    View PubMed
15. Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Reply by Authors. J Urol 2023 May; 209 (5):900 Epub 2023 Apr 07
    View PubMed
16. Lyon TD, Boorjian SA, Tyson MD. In-home Intravesical Therapy: The Future of Nonmuscle-invasive Bladder Cancer Care Delivery? J Urol 2023 Apr; 209 (4):656-658 Epub 2023 Jan 13
    View PubMed
17. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines(R) Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 Mar; 21 (3):236-246
    View PubMed
18. Alsyouf M, Ladi-Seyedian SS, Konety B, Pohar K, Holzbeierlein JM, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S, Blue Light Cystoscopy with Cysview Registry Group. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? Urol Oncol. 2023 Feb; 41 (2):109.e9-109.e14 Epub 2022 Nov 24
    View PubMed
19. Tyson MD. Author Reply. Urology 2023 Jan; 171:132
    View PubMed
20. Tyson MD, Mi L. Preliminary Surgical Outcomes After Single Incision Robotic Cystectomy (SIRC). Urology. 2023 Jan; 171:127-132 Epub 2022 Nov 17
    View PubMed
21. Durant AM, Chang YH, Faraj KS, Tyson MD. BCG Administration after Prior Radiation Treatment for Prostate Cancer. Clin Genitourin Cancer. 2022 Dec; 20 (6):591-597 Epub 2022 June 14
    View PubMed
22. Faraj KS, Mi L, Tyson MD. Patient, Physician, Hospital Factors Associated With Readmission After Radical Cystectomy. Urol Pract. 2022 Nov; 9 (6):589-595 Epub 2022 Nov 01
    View PubMed
23. Faraj KS, Bunn WD, Edmonds VS, Tyson MD. The effect of prior prostate cancer treatment on perioperative and pathological outcomes after cystectomy. Can J Urol. 2022 Oct; 29(5):11284-11290.
    View PubMed
24. Faraj KS, Durant A, Mauler D, Choudry M, Singh R, Chang YH, Tyson MD. Extended Anticoagulation after Radical Cystectomy Using Direct Acting Oral Anticoagulants: A Single-Institutional Experience. Urol Pract. 2022 Sep; 9 (5):451-458 Epub 2022 July 05
    View PubMed
25. Faraj KS, Bunn W, Durant AM, Mauler D, Chang YH, Tyson MD. A comparison of naloxegol versus alvimopan at the time of cystectomy and urinary diversion. Can J Urol. 2022 Aug; 29(4):11209-11215.
    View PubMed
26. Ahmadi H, Ladi-Seyedian SS, Konety B, Pohar K, Holzbeierlein JM, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S, Blue Light Cystoscopy with Cysview Registry Group. Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry. BJU Int. 2022 Jul; 130 (1):62-67 Epub 2021 Oct 26
    View PubMed
27. Lyon TD, Faraj KS, Brennan E, Tyson MD 2nd, Boorjian SA, Spaulding AC. Defining radical cystectomy using the ICD-10 procedure coding system. Urol Oncol. 2022 Apr; 40 (4):165.e17-165.e22 Epub 2021 Oct 26
    View PubMed
28. Chappidi MR, Yang H, Meng MV, Bivalacqua TJ, Daneshmand S, Holzbeierlein JM, Kaimakliotis HZ, Konety B, Liao JC, Pohar K, Steinberg GD, Taylor JM, Tyson MD, Willard B, Lotan Y, Porten SP, Kates M. Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guerin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons. J Urol. 2022 Mar; 207 (3):534-540 Epub 2021 Oct 25
    View PubMed
29. Chevli KK, Shore ND, Trainer A, Smith AB, Saltzstein D, Ehrlich Y, Raman JD, Friedman B, D'Anna R, Morris D, Hu B, Tyson M, Sankin A, Kates M, Linehan J, Scherr D, Kester S, Verni M, Chamie K, Karsh L, Cinman A, Meads A, Lahiri S, Malinowski M, Gabai N, Raju S, Schoenberg M, Seltzer E, Huang WC. Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. J Urol. 2022 Jan; 207 (1):61-69 Epub 2021 Aug 26
    View PubMed
30. Tyson M, Andrews P, Cheney S, Humphreys M. Single Incision Robotic Cystectomy and Hybrid Orthotopic Neobladder Reconstruction: A Step by Step Description. Urology. 2021 Oct; 156:285-288 Epub 2021 July 15
    View PubMed
31. Faraj KS, Edmonds VS, Snider SL, Bunn WD, Tyson MD. Timing of perioperative transversus abdominis plane block at the time of radical cystectomy does not affect perioperative outcomes. Int Urol Nephrol. 2021 Oct; 53(10):2019-2025. Epub 2021 Apr 27.
    View PubMed
32. Faraj KS, Judge N, Chang YH, Blodgett G, Stanton ML, Tyson MD. Variation in Lymph Node Yield After Radical Cystectomy. Am J Clin Pathol. 2021 Aug 4; 156 (3):391-398
    View PubMed
33. Faraj KS, Navaratnam AK, Eversman S, Elias L, Syal A, Tyson MD, Castle EP. Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer. Int Urol Nephrol. 2021 Jun; 53 (6):1111-1118 Epub 2021 Jan 03
    View PubMed
34. Nevo A, Stern KL, Moore JP, Humphreys MR, Tyson MD, Keddis MT. The impact of phone counseling on urinary stone prevention. World J Urol. 2021 May; 39 (5):1625-1629 Epub 2020 June 25
    View PubMed
35. Findlay BL, Britton CJ, Glasgow AE, Gettman MT, Tyson MD, Pak RW, Viers BR, Habermann EB, Ziegelmann MJ. Long-term Success With Diminished Opioid Prescribing After Implementation of Standardized Postoperative Opioid Prescribing Guidelines: An Interrupted Time Series Analysis. Mayo Clin Proc. 2021 May; 96 (5):1135-1146
    View PubMed
36. Faraj KS, Rose KM, Navaratnam AK, Abdul-Muhsin HM, Eversman S, Singh V, Tyson MD. Effect of intracorporeal urinary diversion on the incidence of benign ureteroenteric stricture after cystectomy. Int J Urol. 2021 May; 28 (5):593-597 Epub 2021 Feb 16
    View PubMed
37. Faraj KS, Judge N, Blodgett G, Tyson MD. Relationship between operative duration and perioperative outcomes after radical cystectomy. Can J Urol. 2021 Apr; 28 (2):10603-10609
    View PubMed
38. Abdul-Muhsin H, De Lucia N, Singh V, Faraj K, Rose K, Cha S, Zhang N, Judge N, Navaratnam A, Tyson M, Ho T, Jacobsohn K, Castle E. Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2021 Feb; 39(2):133.e9-133.e16. Epub 2020 Oct 15.
    View PubMed
39. Faraj KS, Mi L, Eversman S, Singh R, DeLucia NM, Blodgett G, Swanson SK, Andrews PE, Ferrigni RG, Humphreys MR, Castle EP, Tyson MD 2nd. The effect of urinary diversion on long-term kidney function after cystectomy. Urol Oncol. 2020 Oct; 38 (10):796.e15-796.e21 Epub 2020 May 30
    View PubMed
40. Tyson M. Editorial Comment. J Urol 2020 Oct; 204 (4):724-725 Epub 2020 July 27
    View PubMed
41. Ziegelmann M, Joseph J, Glasgow A, Tyson M, Pak R, Gazelka H, Leibovich B, Habermann E, Gettman M. Comparison of prescribing patterns before and after implementation of evidence-based opioid prescribing guidelines for the postoperative urologic surgery patient. Am J Surg. 2020 Aug; 220 (2):499-504 Epub 2019 Dec 06
    View PubMed
42. Kamat AM, Lerner SP, O'Donnell M, Georgieva MV, Yang M, Inman BA, Kassouf W, Boorjian SA, Tyson MD, Kulkarni GS, Chang SS, Konety BR, Svatek RS, Balar A, Witjes JA. Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2020 Jun; 3 (3):318-340 Epub 2020 Mar 20
    View PubMed
43. Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Reply by Authors. J Urol 2020 Jun; 203 (6):1093 Epub 2020 Mar 16
    View PubMed
44. Faraj KS, Judge NZ, Rose KM, Eversman S, Richards J, Blodgett G, Singh V, DeLucia NM, Humphreys MR, Castle EP, Tyson MD 2nd. How the Beneficial Effects of Alvimopan Differ With Surgical Approach for Radical Cystectomy. Urology. 2020 Jun; 140:107-114 Epub 2020 Feb 27
    View PubMed
45. Faraj KS, Tyson MD 2nd. AUTHOR REPLY. Urology 2020 Jun; 140:114
    View PubMed
46. Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naive Men: A Systematic Review and Meta-Analysis. J Urol. 2020 Jun; 203 (6):1085-1093 Epub 2019 Oct 14
    View PubMed
47. Rose KM, Carras K, Arora K, Pearson D, Harold K, Tyson M. Robot-assisted repair of ureterosciatic hernia with mesh. J Robot Surg. 2020 Feb; 14 (1):221-225 Epub 2019 Apr 30
    View PubMed
48. Rose KM, Navaratnam AK, Faraj KS, Abdul-Muhsin HM, Syal A, Elias L, Moss AA, Eversman WG, Stone WM, Money SR, Davila VJ, Tyson MD, Castle EP. Comparison of Open and Robot Assisted Radical Nephrectomy With Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic Experience. Urology. 2020 Feb; 136:152-157 Epub 2019 Nov 14
    View PubMed
49. Faraj KS, Abdul-Muhsin HM, Rose KM, Navaratnam AK, Patton MW, Eversman S, Singh R, Eversman WG, Cheney SM, Tyson MD, Castle EP. Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience. Urol Oncol. 2019 Dec; 37 (12):862-869 Epub 2019 Sept 13
    View PubMed
50. Faraj K, Chang YH, Neville MR, Blodgett G, Etzioni DA, Habermann EB, Andrews PE, Castle EP, Humphreys MR, Tyson MD. Robotic vs. open cystectomy: How length-of-stay differences relate conditionally to age. Urol Oncol. 2019 Jun; 37 (6):354.e1-354.e8 Epub 2019 Feb 13
    View PubMed
51. Faraj KS, Abdul-Muhsin HM, Navaratnam AK, Rose KM, Stagg J, Ho TH, Bryce AH, Cheney SM, Tyson MD, Castle EP. Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis: case series and review of the literature. Can J Urol. 2019 Jun; 26 (3):9752-9757
    View PubMed
52. Ziegelmann MJ, Joseph JP, Glasgow AE, Tyson MD, Pak RW, Gazelka HM, Schatz AL, Leibovich BC, Habermann EB, Gettman MT. Wide Variation in Opioid Prescribing After Urological Surgery in Tertiary Care Centers. Mayo Clin Proc. 2019 Feb; 94 (2):262-274
    View PubMed
53. Faba OR, Tyson MD, Artibani W, Bochner BH, Burkhard F, Gilbert SM, Kalble T, Madersbacher S, Seiler R, Skinner EC, Thalmann G, Thuroff J, Wiklund P, Hautmann R, Palou J. Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion. World J Urol. 2019 Jan; 37 (1):85-93 Epub 2018 Sept 20
    View PubMed
54. Tyson MD 2nd, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, McCollum D, Penson DF, Barocas DA. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol. 2018 Jul; 74 (1):26-33 Epub 2018 Feb 28
    View PubMed
55. Tyson MD 2nd, Barocas DA. Quality of Life After Radical Cystectomy. Urol Clin North Am. 2018 May; 45 (2):249-256 Epub 2018 Feb 21
    View PubMed
56. Resnick MJ, Graves AJ, Thapa S, Gambrel R, Tyson MD, Lee D, Buntin MB, Penson DF. Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer Screening. JAMA Intern Med. 2018 May 1; 178 (5):648-654
    View PubMed
57. Tyson MD 2nd, Ark J, Gregg JR, Johnsen NV, Kappa SF, Lee DJ, Smith JA Jr. The Null Effect of Bladder Neck Size on Incontinence Outcomes after Radical Prostatectomy. J Urol. 2017 Dec; 198 (6):1404-1408 Epub 2017 June 24
    View PubMed
58. O'Neil B, Tyson M, Graves AJ, Barocas DA, Chang SS, Penson DF, Resnick MJ. The influence of provider characteristics and market forces on response to financial incentives. Am J Manag Care. 2017 Nov; 23 (11):662-667
    View PubMed
59. Lang MF, Tyson MD, Alvarez JR, Koyama T, Hoffman KE, Resnick MJ, Cooperberg MR, Wu XC, Chen V, Paddock LE, Hamilton AS, Hashibe M, Goodman M, Greenfield S, Kaplan SH, Stroup A, Penson DF, Barocas DA. The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort. Urology. 2017 May; 103:173-178.
    View PubMed
60. Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. JAMA. 2017 Mar 21; 317: (11)1126-1140.
    View PubMed
61. Tyson MD, Lee D, Clark P. New developments in the management of nonmuscle invasive bladder cancer. Curr Opin Oncol. 2017 Mar 09;
    View PubMed
62. Martin CJ, McAdams SB, Abdul-Muhsin H, Lim VM, Nunez-Nateras R, Tyson MD, Humphreys MR. The Economic Implications of a Reusable Flexible Digital Ureteroscope: A Cost-Benefit Analysis. J Urol. 2017 Mar; 197 (3 Pt 1):730-735 Epub 2016 Sept 28
    View PubMed
63. Tyson MD, Penson DF, Resnick MJ. The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer. Urol Oncol. 2017 Feb; 35: (2)51-58.
    View PubMed
64. Abdul-Muhsin H, Tyson M, Raghu S, Humphreys M. The Informed Patient: An Analysis of Information Seeking Behavior and Surgical Outcomes Among Men With Benign Prostatic Hyperplasia. Am J Mens Health. 2017 Jan; 11 (1):147-153 Epub 2016 July 08
    View PubMed
65. Sohn W, Graves AJ, Tyson MD, O'Neil B, Chang SS, Ni S, Barocas DA, Penson DF, Resnick MJ. An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific Survival. J Urol. 2017 Jan; 197: (1)37-43.
    View PubMed
66. Tyson MD, Graves AJ, O'Neil B, Barocas DA, Chang SS, Penson DF, Resnick MJ. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer. JAMA Surg. 2017 Jan 01; 152: (1)27-34.
    View PubMed
67. Abdul-Muhsin H, Tyson M, Raghu S, Humphreys M. The informed patient: an analysis of information seeking behavior and surgical outcomes among men with benign prostatic hyperplasia American Journal of Men's Health. 2017; 11: (1)147-53.
    
68. Tyson MD, Chang SS. Enhanced Recovery Pathways Versus Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes. Eur Urol. 2016 Dec; 70 (6):995-1003 Epub 2016 June 11
    View PubMed
69. Abdul-Muhsin HM, Tyson MD, Stern KL, Nunez-Nateras RA, Humphreys MR. The impact of training on the perioperative and intermediate functional outcomes after holmium laser enucleation of the prostate. Can J Urol. 2016 Dec; 23 (6):8557-8563
    View PubMed
70. Tyson MD, Alvarez J, Koyama T, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, Barocas DA. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. Eur Urol. 2016 Nov 02;
    View PubMed
71. Stern KL, Tyson MD, Abdul-Muhsin HM, Humphreys MR. Contemporary Trends in Percutaneous Nephrolithotomy in the United States: 1998-2011. Urology. 2016 May; 91:41-5.
    View PubMed
72. Scarpato KR, Tyson MD, Clark PE. Natural biology and management of nonmuscle invasive bladder cancer. Curr Opin Oncol. 2016 May; 28: (3)210-5.
    View PubMed
73. Patton MW, Salevitz DA, Tyson MD 2nd, Andrews PE, Ferrigni EN, Nateras RN, Castle EP. Robot-assisted partial nephrectomy for complex renal masses. J Robot Surg. 2016 Mar; 10 (1):27-31 Epub 2015 Dec 24
    View PubMed
74. Abdul-Muhsin HM, Tyson MD, Andrews PE, Castle EP, Ferrigni RG, Wolter CE, Swanson SK, McLemore RY, Humphreys MR. Analysis of Benign Prostatic Hyperplasia Patients' Perspective Through a Third Party-administered Survey. Urology. 2016 Feb; 88:155-60.
    View PubMed
75. Tyson MD 2nd, Andrews PE, Ferrigni RF, Humphreys MR, Parker AS, Castle EP. Radical Prostatectomy Trends in the United States: 1998 to 2011. Mayo Clin Proc. 2016 Jan; 91 (1):10-6
    View PubMed
76. Tyson MD, Wisenbaugh ES, Patton M, Salevitz D, Castle EP. Postoperative changes in serum CO2 as an indicator of postoperative complications after radical cystectomy. Curr Urol Rep. 2015 May; 16 (5):25
    View PubMed
77. Wisenbaugh ES, Tyson MD 2nd, Castle EP, Humphreys MR, Andrews PE. Massive renal size is not a contraindication to a laparoscopic approach for bilateral native nephrectomies in autosomal dominant polycystic kidney disease (ADPKD). BJU Int. 2015 May; 115(5):796-801. Epub 2014 Aug 16.
    View PubMed
78. Salevitz DA, Patton MW, Tyson MD 2nd, Nunez-Nateras R, Ferrigni EN, Andrews PE, Humphreys MR, Castle EP. The impact of ischemia on long-term renal function after partial nephrectomy in the two kidney model. J Endourol. 2015 Apr; 29 (4):474-8 Epub 2014 Nov 05
    View PubMed
79. Tyson MD, Wolter CE. A comparison of 30-day surgical outcomes for minimally invasive and open sacrocolpopexy. Neurourol Urodyn. 2015 Feb; 34(2):151-5. Epub 2013 Nov 22.
    View PubMed
80. Tyson MD, Castle EP, Humphreys MR, Andrews PE. Venous thromboembolism after urological surgery. J Urol. 2014 Sep; 192 (3):793-7 Epub 2014 Mar 02
    View PubMed
81. Klett DE, Tyson MD, Mmeje CO, Nunez-Nateras R, Chang YH, Humphreys MR. Patient-reported sexual outcomes after holmium laser enucleation of the prostate: a 3-year follow-up study. Urology. 2014 Aug; 84(2):421-6. Epub 2014 Jun 21.
    View PubMed
82. Tyson MD, Humphreys MR. Urological applications of natural orifice transluminal endoscopic surgery (NOTES). Nat Rev Urol. 2014 Jun; 11 (6):324-32 Epub 2014 May 13
    View PubMed
83. Tyson MD 2nd, Bryce AH, Ho TH, Carballido EM, Castle EP. Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer. Can J Urol. 2014 Jun; 21 (3):7259-65
    View PubMed
84. Tyson MD, Humphreys MR, Castle EP. Obese patients undergoing cystectomy: a population-based, propensity score matched analysis. Int J Urol. 2014 May; 21(5):491-5. Epub 2013 Nov 20.
    View PubMed
85. Tyson MD 2nd, Humphreys MR. Postoperative complications after percutaneous nephrolithotomy: a contemporary analysis by insurance status in the United States. J Endourol. 2014 Mar; 28 (3):291-7 Epub 2013 Dec 05
    View PubMed
86. Tyson MD, Humphreys MR. Laparoendoscopic single-site surgery, minilaparoscopy and natural orifice transluminal endoscopic surgery in urology. Minerva Urol Nefrol. 2014 Mar; 66: (1)25-35.
    View PubMed
87. Tyson MD 2nd, Castle EP. Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects. Mayo Clin Proc. 2014 Mar; 89 (3):300-7
    View PubMed
88. Tyson MD, Wisenbaugh ES, Andrews PE, Castle EP, Humphreys MR. Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. J Urol. 2013 Dec; 190(6):2170-4. Epub 2013 May 30.
    View PubMed
89. Grimsby GM, Tyson MD, Wolter CE. Comparison of midurethral sling outcomes with and without prolapse repair. Can J Urol. 2013 Oct; 20(5):6927-32.
    View PubMed
90. Tyson MD, Humphreys MR, Parker AS, Thiel DD, Joseph RW, Andrews PE, Castle EP. Age-period-cohort analysis of renal cell carcinoma in United States adults. Urology. 2013 Jul; 82 (1):43-7 Epub 2013 May 22
    View PubMed
91. Tyson MD, Andrews PE, Etzioni DA, Ferrigni RG, Humphreys MR, Swanson SK, Castle EK. Marital status and prostate cancer outcomes. Can J Urol. 2013 Apr; 20 (2):6702-6
    View PubMed
92. Tyson MD, Hurd KJ, Nunez RN, Wolter CE, Humphreys MR. Temporary prostatic urethral stenting as a provocative tool to determine surgical eligibility in complex bladder outlet obstructed patients: our initial experience. Curr Urol. 2012 Sep; 6 (2):82-6 Epub 2012 Sept 27
    View PubMed
93. Warner JN, Grimsby GM, Tyson MD, Wolter CE. Bladder capacity on preoperative urodynamics may impact outcomes on transobturator male slings. Neurourol Urodyn. 2012 Sep; 31(7):1124-7. Epub 2012 May 11.
    View PubMed
94. Hamilton AR, Tyson MD, Braga JA, Lerner LB. Childbearing and pregnancy characteristics of female orthopaedic surgeons. J Bone Joint Surg Am. 2012 Jun 6; 94(11):e77.
    View PubMed
95. Grimsby GM, Tyson MD, Salevitz B, Smith ML, Castle EP. Bladder Outlet Obstruction Secondary to a Brunn's Cyst. Curr Urol. 2012 May; 6 (1):50-2 Epub 2012 Apr 30
    View PubMed
96. Wisenbaugh ES, Stanton ML, Grimsby GM, Tyson MD, Castle EP. Metastatic malignant melanoma to the bladder: a case series. Curr Urol. 2012 May; 6 (1):53-6 Epub 2012 Apr 30
    View PubMed
97. Tyson MD, Castle EP, Andrews PE, Heilman RL, Moss AA, Mulligan DC, Reddy KS. Ureteral stricture formation in laparoscopically procured living donor kidney transplantation. Can J Urol. 2012 Apr; 19(2):6188-92.
    View PubMed
98. Tyson MD, Etzioni DA, Wisenbaugh ES, Andrews PE, Humphreys MR, Ferrigni RG, Swanson SK, Castle EP. Anatomic site-specific disparities in survival outcomes for penile squamous cell carcinoma. Urology. 2012 Apr; 79 (4):804-8 Epub 2012 Mar 03
    View PubMed
99. Grimsby GM, Tyson MD, Wolter CE. Early outcomes of the transobturator male sling based on body mass index. Can J Urol. 2012 Feb; 19(1):6088-93.
    View PubMed
100. Warner JN, Nunez RN, Tyson MD, Viprakasit DP, Miller NL, Humphreys MR. A multiinstitutional study of the effects of medical therapy for lower urinary symptoms on the perioperative outcomes of holmium laser enucleation of the prostate. Urology. 2011 Dec; 78(6):1385-90. Epub 2011 Aug 25.
     View PubMed
101. Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Living donor kidney transplantation with multiple renal arteries in the laparoscopic era. Urology. 2011 May; 77(5):1116-21. Epub 2010 Dec 08.
     View PubMed
102. Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Living donor kidney transplantation with multiple renal arteries in the laparoscopic era. International Braz J Urol. 2011; 37(3):401.
     
103. Lerner LB, Tyson MD, Mendoza PJ. Stress incontinence during the learning curve of holmium laser enucleation of the prostate. J Endourol. 2010 Oct; 24(10):1655-8.
     View PubMed
104. Tyson M, Castle E, Andrews P, Heilman R, Mekeel K, Moss A, Mulligan D, Reddy K. Early graft function after laparoscopically procured living donor kidney transplantation. J Urol. 2010 Oct; 184(4):1434-9. Epub 2010 Aug 19.
     View PubMed
105. Tyson MD, Lerner LB. Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol. 2009 Aug; 23(8):1343-6.
     
106. Tyson MD, French M, McNulty N, Lerner LB. A case of severe bladder wall hypertrophy: cancer or sequela of bladder outlet obstruction?. Can J Urol. 2009 Feb; 16(1):4516-8.
     
107. Tyson MD, Lerner LB. Profile of a VA urologist: results from a national survey. J Urol. 2008 Oct; 180(4):1460-2.
     
108. Lerner LB, Tyson MD. Intralesional verapamil treatment for peyronie's disease: an analysis of erectile and sexual function in a small cohort of veterans. Fed Prac USA. 2008; 25(7):19-22.
     
109. Wang D, Tyson MD, Jackson S, Yadegari R. Partially redundant functions of two SET-domain polycomb-group proteins in controlling initiation of seed development in Arabidopsis. Proc Natl Acad Sci USA. 2006 Aug 29; 103(35):13244-9.